A father recounts how LAF and advocacy helped him move past the grief of his son's death from leukemia.
New ways to find prostate cancer and gauge its aggressiveness help patients make better choices.
Patrick Dempsey discusses National Ovarian Cancer Awareness Month.
Want to support someone during cancer treatment? Offer your ear, not your opinion.
New advances in radiation treatment enable higher doses with less damage to nearby tissue.
Axel Hoos, M.D., Ph.D. of GlaxoSmithKline discusses the ATOM Initiative.
A recent study looked at a two-week preoperative intervention for lung cancer resection that included an intervention intended for emotional balance: mindfulness.
After finding out she had an MPN, Barbara Abernathy, Ph.D., like many other people, felt numb. But then it was time to find her fight mode.
When healing comes from quiet corners, soft words and family moments.
As coronavirus fears escalate, a physician with stage 4 lung cancer reflects on protecting personal health and aiding the global community.
There’s been some debate in recent years about the true value and effectiveness of certain types of cancer screenings. This is, of course, a perfectly reasonable thing to be doing both in the name of advancing medical science, and especially in an environment where there's so much downward pressure on the costs of healthcare.
How much better can I help people now that I have been through it myself?
The genetic differences that distinguish men’s breast cancers may lead to new diagnosis and treatment options.
An Extraordinary Healer essay honoring JOAN SUCH LOCKHART, PH.D., RN, AOCN, CNE, ANEF, FAAN [DUQUESNE UNIVERSITY SCHOOL OF NURSING, PITTSBURGH, PENNSYLVANIA]
Certain types of cancer treatments can result in the body having too few platelets, a condition called thrombocytopenia, which can increase the risk of bleeding.
Looking back at my experience with osteosarcoma, I realized that managing the mental game was half the battle, especially with so much negativity.
Michael J. Mauro, provides an overview of some of the questions he hears from patients with chronic myeloid leukemia (CML).
Reduce breast cancer risk through diet and lifestyle.
Remembering and honoring his mother’s memory, a son recalls one of her last days.
If your chair was cold, I knew you were two floors down in the NICU cradling your only child – the only one I’d be able to give you – making sure his IV and nutrition lines were also connected and beeping lively and skipping at the same beat as mine.
Having been a caregiver to my late husband who died from cancer, I know first-hand the difficulties of caregiving — not to mention what it must be like for those trying to do it during a worldwide pandemic.
MY WIFE passed away on Feb. 2, 2014, from a six-year battle with cancer. It is my honor to nominate one angel in particular who, in the end, became much more than a nurse to my wife.
An Extraordinary Healer essay honoring Carol Mallon, RN, MS, OCN [ Penn State Hershey Medical Center Cancer Institute in Hershey, Pennsylvania ]
An Extraordinary Healer essay honoring Debbie Cherry, LPN [ St. Jude Children's Research Hospital in Memphis, Tennessee ]
Bruton tyrosine kinase inhibitors have changed the space for treating patients with CLL or SLL, with more on the way to potentially address drug resistance.
Adaptive Clinical Trial Design Is More Cost Effective, Patient-Centric and Allows for Faster Learning Than Standard Trials
Superior progression-free survival (PFS) was seen in patients with ovarian cancer who previously had a partial response (PR) to platinum-based therapy when they took Zejula (niraparib). This response was seen in patients with or without germline BRCA mutations, according to data from the ENGOT-OV16/NOVA trial presented at the 2017 ASCO Annual Meeting.